Abstract
The present study is concerned with the synthesis, anticancer and antimicrobial screening of several new 3-substituted or 2,3-disubstituted-5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-6-carboxamide derivatives. Three compounds (4b, 8c, and 11b) were selected by the National Cancer Institute and were first evaluated at a single-dose primary anticancer assay against 60 human cancer cell lines for their in vitro anticancer activity. Compound 8c which passed the criteria for activity in this assay was evaluated against the full panel of 60 human cancer cell lines at five concentrations at tenfold dilutions where it showed non-selective broad-spectrum activity against all cancer cell lines. Furthermore, compounds 4b, 6, 8c, 8d, and 16 showed pronounced antibacterial activities comparable to ampicillin against P. aeruginosa. Therefore, it was concluded that compound 8c may serve as a useful lead compound in search for powerful dual anticancer-antimicrobial agents.
Similar content being viewed by others
References
Al-Smadi M, Al-Momani F (2008) Synthesis, characterization and antimicrobial activity of new 1,2,3-selenadiazoles. Molecules 13:2740–2749
Badawey E, Rida SM, Hazzaa AA, Fahmy HTY, Gohar YM (1993) Potential anti-microbials. I. Synthesis and structure-activity studies of some new thiazolo[4,5-d]pyrimidine derivatives. Eur J Med Chem 28:91–96
Bekhit AA, Habib NS, Park JY (2004) Synthesis of some thiazolyl and thiadiazolyl derivatives of 4(3H)-quinazolinone as anti-inflammatory-antimicrobial agents. Boll Chim Farm 143:34–39
Bondock S, Khalifa W, Fadda AA (2007) Synthesis and antimicrobial evaluation of some new thiazole, thiazolidinone and thiazoline derivatives starting from 1-chloro-3,4-dihydronaphthalene-2-carboxaldehyde. Eur J Med Chem 42(7):948–954
Boyd MR (1997) The NCI in vitro anticancer drug discovery screen; concept, implementation and operation 1985–1995, in Cancer drug discovery and development. In: Teicher BA (ed) Drug development: Preclinical screening, clinical trial and approval, vol 2. Humana, Totowa, pp 23–42
Boyd MR, Paull KD (1995) Some practical considerations and applications of the national cancer institute In vitro anticancer drug discovery screen. Drug Dev Res 34:91–109
Chakraborti AK, Gopalakrishnan B, Sobhia ME, Malde A (2003) 3D-QSAR Studies on thieno[3,2-d]pyrimidines as Phosphodiesterase IV Inhibitors. Bioorg Med Chem Lett 13(8):1403–1408
Comber RN, Gray RJ, Secrist JA (1991) Acyclic analogues of pyrazofurin: syntheses and antiviral evaluation. Carbohydr Res 216:441–452
Cunha S, Macedo FC Jr, Costa GAN, Rodrigues MT Jr, Verde RBV, de Souza Neta LC, Vencato I, Lariucci C, Sa FP (2007) Antimicrobial activity and structural study of disubstituted thiourea derivatives. Monatsh Chem 138:511–516
Donkor IO, Li H, Queener SF (2003) Synthesis and DHFR inhibitory activity of a series of 6-substituted-2,4-diaminothieno[2,3-d]pyrimidines. Eur J Med Chem 38(6):605–611
Du AY, Zhao BX, Yin DL, Zhang SL, Miao JY (2005) Discovery of a novel small molecule, 1-ethoxy-3-(3,4-methylenedioxyphenyl)-2-propanol, that induces apoptosis in A549 human lung cancer cells. Bioorg Med Chem 13(13):4176–4183
Eckhardt S (2002) Recent progress in the development of anticancer agents. Curr Med Chem Anticancer Agents 2(3):419–439
Eissa AAHM, Moneer AA (2004) Synthesis and antimicrobial activity of novel tetrahydrobenzothienopyrimidines. Arch Pharm Res 27:885–892
El-Ansary AK, Omar AH (2001) Synthesis and anti-inflammatory activity of some thieno[2,3-d]pyrimidinone derivatives. Bull Fac Pharm Cairo Univ 39(1):17–25
El-Baih FEM, Al-Blowy HAS, Al-Hazimi HM (2006) Synthesis of Some Thienopyrimidine Derivatives. Molecules 11:498–513
El-Emam AA, Ibrahim TM (1991) Synthesis and anti-inflammatory and analgesic activity of some 3-(1-adamantyl)-4-substituted-5-mercapto-1,2,4-triazoles. Arzneim-Forsch Drug Res 41:1260–1264
El-Feky SAH (1993) Synthesis and anticonvulsant properties of some novel quinazolinone thiazolidine and 4-thiazolidone derivatives. Pharmazie 48:894–896
El-Hawash SA, Habib NS, Fanaki NH (1999) Quinoxaline derivatives part II: synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines,1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines. Pharmazie 54:808–813
El-Hawash SA, Habib NS, Kassem MA (2006) Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines for evaluation of in vitro antitumor and antimicrobial activities. Arch Pharm 339:564–571
El-Meligie S, El-Ansary AK, Said MM, Hussien MMM (2001) Synthesis and antimicrobial activity of 2-(2-aryl vinyl)-7-substituted-quinazolin-4(3H)-ones. Indian J Chem 40B:62–69
Gewald K, Schinke E, Bottcher H (1966) Heterocycles from CH-acidic nitriles. VIII. 2-Aminothiophenes from methylene-active nitriles, carbonyl compounds, and sulfur. Chem Ber 99(1):94–100
Habib NS, El-Hawash SA (2005) Quinoxalines part III: anticancer activity of some quinoxaline derivatives. Boll Chim Farm 144:1–17
Habib NS, Soliman R, Ismail K, Hassan AM, Sarg MT (2003) Pyrimidines part II: synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities. Boll Chim Farm 142:396–405
Hallur G, Jimeno A, Dalrymple S, Zhu T, Jung MK, Hidalgo M, Isaacs JT, Sukumar S, Hamel E, Khan SR (2006) Benzoylphenylurea sulfur analogues with potent antitumor activity. J Med Chem 49(7):2357–2360
Haruna K, Kanezaki H, Tanabe K, Dai WM, Nishimoto S (2006) Effects of structural modification on the DNA binding properties and photo-induced cleavage reactivity of propargylic sulfones conjugated with an anthraquinone structure. Bioorg Med Chem 14(13):4427–4432
Jain SR, Kar A (1971) The antibacterial activity of some essential oils and their combinations. Planta Med 20:118–123
Jennings LD, Kincaid SL, Wang YD, Krishnamurthy G, Beyer CF, McGinnis JP, Miranda M, Discafani CM, Rabindran SK (2005) Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells. Bioorg Med Chem Lett 15:4731–4735
Kutschy P, Salayova A, Curillova Z, Kozar T, Mezencev R, Mojzis J, Pilatova M, Balentova E, Pazdera P, Sabol M, Zburova M (2009) 2-(Substituted phenyl)amino analogs of 1-methoxyspirobrassinol methyl ether: synthesis and anticancer activity. Bioorg Med Chem 17(10):3698–3712
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83(11):757–766
Munchhof MJ, Beebe JS, Casavant JM, Cooper BA, Doty JL, Higdon RC, Hillerman SM, Soderstrom CI, Knauth EA, Marx MA, Rossi AMK, Sobolov SB, Sun J (2004) Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity. Bioorg Med Chem Lett 14(1):21–24
Nasr MN, Gineinah MM (2002) Pyrido[2,3-d]pyrimidines and Pyrimido[5′,4′:5,6]pyrido[2,3-d]pyrimidines as new antiviral agents: synthesis and biological activity. Arch Pharm Pharm Med Chem 335(6):289–295
Nomoto Y, Takai H, Ohno T, Kubo K (1991) Studies on cardiotonic agents. VI. Synthesis of novel 4,5-dihydro-3(2H)-pyridazinone derivatives carrying some benzoheterocycles at the 6-position. Chem Pharm Bull 39(2):352–357
Omar AMME, AboulWafa OM (1984) Novel estradiol-17α-1,2,4-triazoline derivatives. Synthesis and in vitro anabolic-catabolic properties and binding affinity to steroid receptors. J Heterocycl Chem 21:1419–1423
Omar AMME, AboulWafa OM, Hazzaa AAB, El-Samahy SA (2005) Novel triazole and triazoline derivatives fused to thieno[2,3-d]pyrimidin-5(4H)-one as potential antimicrobial agents. Alex J Pharm Sci 19:97–105
Ottana R, Carotti S, Maccari R, Landini I, Chiricosta G, Caciagli B, Vigorita MG, Mini E (2005) In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. Bioorg Med Chem Lett 15(17):3930–3933
Patil BS, Krishnamurthy G, Naik HSB, Latthe PR, Ghate M (2010) Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro[1,2,4]triazolo-3-ones and their corresponding sulfones. Eur J Med Chem 45(8):3329–3334
Pillai AD, Rathod PD, Franklin PX, Patel M, Nivsarkar M, Vasu KK, Padh H, Sudarsanam V (2003) Novel drug designing approach for dual inhibitors as anti-inflammatory agents: implication of pyridine template. Biochem Biophys Res Commun 301:183–187
Raic-Malic S, Grdisa M, Pavelic K, Mintas M (1999) Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties. Eur J Med Chem 34(5):405–413
Ritter JM, Lewis LD, Mant TG, Ferro A (eds) (2008) Drugs in the elderly. In: A textbook of clinical pharmacology and therapeutics, 5th edn. Hodder Arnold, Hachette Livre, London, pp 56–61
Roche VF (2008) Cancer and Chemotherapy. In: Lemke TL, Roche VF, Williams DA, Zito SW (eds) Foye’s principles of medicinal chemistry, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 1153
Scott AC (1989) Laboratory control of antimicrobial therapy. In: Collee JG, Duguid JP, Fraser AG, Marmion BP (eds) Mackie and McCartney practical medical microbiology, vol 2, 13th edn. Churchill Livingstone, Edinburgh, pp 161–181
Shehata IA, El-Subbagh HI, Abdelal AM, El-Sherbeny MA, Al-Obaid AA (1996) Synthesis, antitumor and anti-HIV-1 testing of certain thieno[2,3-d]pyrimidine, thieno[2,3-d]imidazo[1,2-c]pyrimidine and thieno[2,3-d][1,3]thiazine derivatives. Med Chem Res 6:148–163
Shoemaker RH (2006) The NCI 60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6(10):813–823
Soliman R, Habib NS, Ismail K, Moustafa A, Sarg MT, Fanaki NH (2003) Synthesis of novel pyrimidine-2,4-diones and 2-thioxopyrimidine-4-ones as potential anticancer and antimicrobial agents. Boll Chim Farm 142:167–174
Soliman R, Habib NS, El-Tombary AA, El-Hawash SAM, Shaaban OG (2009) Synthesis of tetrahydrobenzothieno[2,3-d]pyrimidine and tetrahydrobenzothieno[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as potential antimicrobial agents. Sci Pharm 77:755–773
Venkatachalam SR, Salaskar A, Chattopadhyay A, Barik A, Mishra B, Gangabhagirathic R, Priyadarsini KI (2006) Synthesis, pulse radiolysis, and in vitro radioprotection studies of melatoninolipoamide, a novel conjugate of melatonin and α-lipoic acid. Bioorg Med Chem 14:6414–6419
Williams DA (2008) Drug metabolism. In: Lemke TL, Roche VF, Williams DA, Zito SW (eds) Foye’s principles of medicinal chemistry, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 295–296
Zhao LM, Xie TP, He YQ, Xu DF, Li SS (2009) Synthesis and antitumor activity of 6- and 2-(1-substituted-thio-4-methylpent-3-enyl)-5,8-dimethoxynaphthalene-1,4-diones. Eur J Med Chem 44(4):1410–1414
Acknowledgments
The authors thank the members of the Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, U.S.A. for carrying out the in vitro anticancer screening and members of the Department of Microbiology, Faculty of Pharmacy, University of Alexandria, for performing the in vitro antimicrobial screening.
Conflict of interest
The authors have declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Habib, N.S., Soliman, R., El-Tombary, A.A. et al. Synthesis and biological evaluation of novel series of thieno[2,3-d]pyrimidine derivatives as anticancer and antimicrobial agents. Med Chem Res 22, 3289–3308 (2013). https://doi.org/10.1007/s00044-012-0324-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-012-0324-3